Blood test kit

Information

  • Patent Grant
  • D770057
  • Patent Number
    D770,057
  • Date Filed
    Tuesday, September 23, 2014
    10 years ago
  • Date Issued
    Tuesday, October 25, 2016
    8 years ago
  • US Classifications
    Field of Search
    • US
    • D24 121
    • D24 216
    • D24 222-232
    • D10 78
    • D10 81
    • D10 103
    • 422 408000
    • 422 430000
    • 422 501-504
    • 422 068100
    • 422 547000
    • 422 067000
    • 422 411000
    • 422 401000
    • 422 420000
    • 436 163000
    • 436 164000
    • 436 169000
    • 435 006160
    • 435 091100
    • 435 006110
    • 435 287100
    • 435 287200
    • 435 007100
    • 435 007900
    • 600 300000
    • 600 583-584
    • 356 440000
    • 356 445000
    • CPC
    • B01J19/0046
    • G01N31/221
    • G01N31/22
    • G01N21/8483
    • G01N21/6428
    • G01N21/07
    • G01N21/774
    • G01N33/54366
    • G01N21/474
    • G01N33/76
    • G01N21/278
    • G01N33/558
    • B01L2400/0406
    • B01L9/54
    • B01L2300/0816
    • B01L3/502707
    • B01L3/5025
    • B01L3/5023
  • International Classifications
    • 2402
    • Term of Grant
      14Years
Abstract
Description


FIG. 1 is a front perspective view of a blood test kit showing the new design.



FIG. 2 is a top plan view thereof.



FIG. 3 is a bottom plan view thereof.



FIG. 4 is a left side view thereof.



FIG. 5 is a right side view thereof.



FIG. 6 is a front end side view thereof; and,



FIG. 7 is a back end side view thereof.


The features shown in broken lines in the drawings depict environmental subject matter only and form no part of the claimed design.


Claims
  • The ornamental design for a blood test kit, as shown and described.
Priority Claims (2)
Number Date Country Kind
2447078-2 Apr 2014 EP regional
2447078-3 Apr 2014 EP regional
US Referenced Citations (28)
Number Name Date Kind
5728587 Kang Mar 1998 A
5939331 Burd Aug 1999 A
6239445 Shaeef May 2001 B1
6267722 Anderson Jul 2001 B1
D454398 Robertson Mar 2002 S
D456082 Bouse Apr 2002 S
D467348 McMichael Dec 2002 S
D468437 McMenamy Jan 2003 S
D495805 Lea Sep 2004 S
D500142 Crisanti Dec 2004 S
6855561 Jerome Feb 2005 B2
D512512 Bell Dec 2005 S
D531321 Godfrey Oct 2006 S
7285425 Shareef Oct 2007 B2
D561344 Kozak Feb 2008 S
7326578 Bateman Feb 2008 B2
D602599 Xiaowei Oct 2009 S
7847946 Krauth Dec 2010 B2
D639977 Francis Jun 2011 S
D640389 Francis Jun 2011 S
D655424 Castanon Mar 2012 S
D660977 Wagner May 2012 S
D660978 Wagner May 2012 S
8268636 Nazareth Sep 2012 B2
D668350 Rowley Oct 2012 S
D668779 Khan Oct 2012 S
8278109 Nazareth Oct 2012 B2
D676570 Chance Feb 2013 S
Non-Patent Literature Citations (3)
Entry
Sanada, et al.,“IL-33 and ST2 Comprise a Critical Biomechanically Induced and Cardioprotective Signaling System”; The Journal of Clinical Investigation; May 10, 2007.
Sanchez-Mas, et al.; “Modulcation of IL-33/ST2 System in Postinfraction Heart Failure: correlation with Cardiac Remodeling Markers”; European Journal of Clinical Investigation; vol. 44; 2014; pp. 643-651.
Seki, et al., “Interleukin-33 Prevents Apoptosis and Improves survival After Experimental Myocardial Infarction Through ST2 Signaling”; American Heart Association; Feb. 16, 2010.